Docking results of effective compounds in TFDM. by Xu Hu (23350)

“…</p><p>Results</p><p>21 active components were screened, 158 potential drug targets for the prevention and treatment of CIRI were obtained, 53 main targets were further screened in the protein-protein interaction network, and 106 signal pathways, 76 biological processes, 26 cell components and 50 molecular functions were enriched (P<0.05). Through the compound-target-pathway network, the key compounds that play a role in the prevention and treatment of CIRI, such as acacetin, apigenin and other flavonoids, as well as the corresponding key targets and key signal pathways, such as AKT1, SRC and EGFR were obtained. …”

Active compounds screened from TFDM. by Xu Hu (23350)

“…</p><p>Results</p><p>21 active components were screened, 158 potential drug targets for the prevention and treatment of CIRI were obtained, 53 main targets were further screened in the protein-protein interaction network, and 106 signal pathways, 76 biological processes, 26 cell components and 50 molecular functions were enriched (P<0.05). Through the compound-target-pathway network, the key compounds that play a role in the prevention and treatment of CIRI, such as acacetin, apigenin and other flavonoids, as well as the corresponding key targets and key signal pathways, such as AKT1, SRC and EGFR were obtained. …”

Network of compound-target-pathway. by Xu Hu (23350)

“…</p><p>Results</p><p>21 active components were screened, 158 potential drug targets for the prevention and treatment of CIRI were obtained, 53 main targets were further screened in the protein-protein interaction network, and 106 signal pathways, 76 biological processes, 26 cell components and 50 molecular functions were enriched (P<0.05). Through the compound-target-pathway network, the key compounds that play a role in the prevention and treatment of CIRI, such as acacetin, apigenin and other flavonoids, as well as the corresponding key targets and key signal pathways, such as AKT1, SRC and EGFR were obtained. …”

Results of the DSA for the number of referrals to TVS. by Benjamin Ruban-Fell (10791208)

Analysis of the oncogenic pathways regulated by DMKN. by Wenqiong Ma (13259891)

“…<p>(A-B) the DMK disruption of MET/EMT cortical actin, increased expression of epithelial markers (E-cadherin), and decreased expression of mesenchymal markers (N-cadherin, Vimentin, and Snail). …”

Results of the DSA for the number of diagnosed VP cases. by Benjamin Ruban-Fell (10791208)

Results of the PSA for the difference versus no screening (number of referrals to TVS and number of diagnosed VP cases). by Benjamin Ruban-Fell (10791208)

40 years of immunization in Mozambique: a narrative review of literature, accomplishments, and perspectives by Marta Cassocera (8748219)

Removal of bisphenol A by adsorption on organically modified clays from Burkina Faso by Issaka Garikoé (9604658)

α-GalCer expanded iNKT cells from SLE patients had deficient perforin expression but comparable ability to enhance NK cytotoxicity. by Chien-Ya Hsu (11868746)

IL-15 enhanced CD69, CD1d, and CD11a expression of α-GalCer-treated iNKT cells in SLE patients. by Chien-Ya Hsu (11868746)

pI7L suppresses the IFN-<i>γ</i>-triggered JAK-STAT signaling pathway. by Meilin Li (1832905)

Effects of <i>A</i>. <i>simplex</i> CE on TJ proteins. by Noelia Carballeda-Sangiao (2889611)

Development of the Nb474H/IgM8A2-B “hybrid” sandwich ELISA prototype. by Steven Odongo (2143756)

“…A high signal intensity (OD_450nm) observed at higher concentrations of IgM8A2-B tapered with the decreasing concentrations of the mAb indicating that Strep-HRP was binding coated IgM8A2-B. …”

C/EBPα binds five sites within the <i>Cebpa</i> +8 kb enhancer. by Lei Peng (260321)

pI7L inhibits STAT1 phosphorylation and blocks its nuclear translocation. by Meilin Li (1832905)

Defective response to α-GalCer in SLE CD161⁺ iNKT cells restored by IL-15. by Chien-Ya Hsu (11868746)

Deficient α-GalCer-induced expansion of iNKT cells and poor response to IL-15 in SLE patients. by Chien-Ya Hsu (11868746)

IL-4, but not interferon-γ expression is deficient in iNKT cells from SLE patient. by Chien-Ya Hsu (11868746)

Effect of IL-15 +α-GalCer stimulation on the percentages of CD3⁺/CD56⁺ NKT-like cells in SLE MNCs. by Chien-Ya Hsu (11868746)